Found: 49
Select item for more details and to access through your institution.
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant-Reply.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Antithrombotic therapy in the management of hospitalised patients with COVID-19.
- Published in:
- British Journal of Hospital Medicine (17508460), 2023, v. 84, n. 5, p. 1, doi. 10.12968/hmed.2022.0519
- By:
- Publication type:
- Article
New Paradigms of Extended Thromboprophylaxis in Medically Ill Patients.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 1002, doi. 10.3390/jcm9041002
- By:
- Publication type:
- Article
Prevention of venous thromboembolism: Clinical and economic implications.
- Published in:
- American Journal of Health-System Pharmacy, 2006, v. 63, p. S3, doi. 10.2146/ajhp060387
- By:
- Publication type:
- Article
Prevention of venous thromboembolism: Clinical and economic implications.
- Published in:
- American Journal of Health-System Pharmacy, 2006, v. 63, n. 20, p. S3, doi. 10.2146/ajhp060387
- By:
- Publication type:
- Article
ASHP Therapeutic Position Statement on the Role of Pharmacotherapy in Preventing Venous Thromboembolism in Hospitalized Patients.
- Published in:
- American Journal of Health-System Pharmacy, 2012, v. 69, n. 24, p. 2174, doi. 10.2146/ajhp120236
- By:
- Publication type:
- Article
Venous thromboembolism following hematopoietic stem cell transplantation-a systematic review and meta-analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Purple Toes Syndrome Associated with Warfarin Therapy in a Patient with Antiphospholipid Syndrome.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 5, p. 674, doi. 10.1592/phco.23.5.674.32200
- By:
- Publication type:
- Article
Anticoagulation with Anisindione in a Patient with a Warfarin-Induced Skin Eruption.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 4, p. 533, doi. 10.1592/phco.23.4.533.32130
- By:
- Publication type:
- Article
System-Wide Thromboprophylaxis Interventions for Hospitalized Patients at Risk of Venous Thromboembolism: Focus on Cross-Platform Clinical Decision Support.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 7, p. 2133, doi. 10.3390/jcm13072133
- By:
- Publication type:
- Article
Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 20, p. 5997, doi. 10.3390/jcm11205997
- By:
- Publication type:
- Article
Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 22, p. 5366, doi. 10.3390/jcm10225366
- By:
- Publication type:
- Article
Perioperative Management of Patients Taking Direct Oral Anticoagulants: A Review.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 332, n. 10, p. 825, doi. 10.1001/jama.2024.12708
- By:
- Publication type:
- Article
Prevention of Bleeding in Older Patients Taking Warfarin.
- Published in:
- Annals of Internal Medicine, 2001, v. 135, n. 7, p. 548, doi. 10.7326/0003-4819-135-7-200110020-00015
- By:
- Publication type:
- Article
Thromboprophylaxis in critical care.
- Published in:
- Intensive Care Medicine, 2023, v. 49, n. 1, p. 75, doi. 10.1007/s00134-022-06850-7
- By:
- Publication type:
- Article
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Incidence and Prognostic Implications of Readmissions Caused by Thrombotic Events After a Heart Failure Hospitalization.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Benefit-Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 3, p. 330, doi. 10.1007/s12185-021-03078-x
- By:
- Publication type:
- Article
A Disease Management Protocol for Outpatient Perioperative Bridge Therapy with Enoxaparin in Patients Requiring Temporary Interruption of Long-Term Oral Anticoagulation.
- Published in:
- Pharmacotherapy, 2004, v. 24, n. 5, p. 649, doi. 10.1592/phco.24.6.649.34740
- By:
- Publication type:
- Article
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2021, v. 52, n. 4, p. 1032, doi. 10.1007/s11239-021-02504-5
- By:
- Publication type:
- Article
Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2021, v. 51, n. 4, p. 897, doi. 10.1007/s11239-021-02413-7
- By:
- Publication type:
- Article
Using big data to retrospectively validate the COMPASS-CAT risk assessment model: considerations on methodology.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2021, v. 51, n. 1, p. 12, doi. 10.1007/s11239-020-02191-8
- By:
- Publication type:
- Article
Does telehealth improve anticoagulation management in patient service centers (PSC)? A pilot project.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 316, doi. 10.1007/s11239-019-02031-4
- By:
- Publication type:
- Article
Quality metrics of warfarin initiation in hospitalized older adults.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2019, v. 48, n. 3, p. 459, doi. 10.1007/s11239-019-01905-x
- By:
- Publication type:
- Article
Assessment of warfarin algorithms for hospitalized adults: searching for a safe dosing strategy.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2019, v. 48, n. 4, p. 570, doi. 10.1007/s11239-019-01902-0
- By:
- Publication type:
- Article
External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS‐CAT Venous Thromboembolism Risk Assessment Model.
- Published in:
- Oncologist, 2020, v. 25, n. 7, p. e1083, doi. 10.1634/theoncologist.2019-0482
- By:
- Publication type:
- Article
A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.
- Published in:
- Oncologist, 2017, v. 22, n. 10, p. 1222, doi. 10.1634/theoncologist.2016-0414
- By:
- Publication type:
- Article
Management of Venous Thromboembolism in the Elderly.
- Published in:
- Drugs & Aging, 2006, v. 23, n. 8, p. 651, doi. 10.2165/00002512-200623080-00003
- By:
- Publication type:
- Article
Features of Electronic Health Records Necessary for the Delivery of Optimized Anticoagulant Therapy: Consensus of the EHR Task Force of the New York State Anticoagulation Coalition.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 113, doi. 10.1177/1060028014555176
- By:
- Publication type:
- Article
Sex-Based Differences in COVID-19 Outcomes.
- Published in:
- Journal of Women's Health (15409996), 2021, v. 30, n. 4, p. 492, doi. 10.1089/jwh.2020.8974
- By:
- Publication type:
- Article
Implementation of the Management of Anticoagulation in the Periprocedural Period App into an Electronic Health Record: A Cost-Effectiveness Analysis.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2023, v. 29, p. 1, doi. 10.1177/10760296231154553
- By:
- Publication type:
- Article
Real-World Analysis of Thromboembolic Events and Mortality of COVID-19 Outpatients in the United States.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2022, v. 28, p. 1, doi. 10.1177/10760296221120421
- By:
- Publication type:
- Article
Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2022, v. 28, p. 1, doi. 10.1177/10760296221110568
- By:
- Publication type:
- Article
Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2021, v. 27, p. 1, doi. 10.1177/10760296211053316
- By:
- Publication type:
- Article
Implementation of the Management of Anticoagulation in the Periprocedural Period App Into an Electronic Health Record: A Prospective Cohort Study.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2020, v. 26, p. 1, doi. 10.1177/1076029620925910
- By:
- Publication type:
- Article
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2019, v. 25, p. 1, doi. 10.1177/1076029619886022
- By:
- Publication type:
- Article
Proportion of US Hospitalized Medically Ill Patients Who May Qualify for Extended Thromboprophylaxis.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2019, v. 25, p. 1, doi. 10.1177/1076029619850897
- By:
- Publication type:
- Article
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2018, v. 24, n. 4, p. 575, doi. 10.1177/1076029618758955
- By:
- Publication type:
- Article
Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated With Different Outcomes Among Patients With Venous Thromboembolism?
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2017, v. 23, n. 6, p. 532, doi. 10.1177/1076029616680475
- By:
- Publication type:
- Article
Antithrombotic Medication Use and Bleeding Risk in Medically Ill Patients After Hospitalization.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2013, v. 19, n. 5, p. 504, doi. 10.1177/1076029612470967
- By:
- Publication type:
- Article
Venous Thromboembolism Pharmacy Intervention Management Program With an Active, Multifaceted Approach Reduces Preventable Venous Thromboembolism and Increases Appropriate Prophylaxis.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2012, v. 18, n. 1, p. 45, doi. 10.1177/1076029611405186
- By:
- Publication type:
- Article